Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio Fund Management (BioFund) was a leading venture capital firm based in Helsinki, Finland, that focused exclusively on the life sciences, biotechnology, and healthcare sectors. Established in 1997, the firm managed a series of funds known as Bio Fund Ventures I, II, and III, becoming one of the largest specialized healthcare investors in Northern Europe. The firm played a pivotal role in the development of the Nordic biotech ecosystem by providing critical early-stage and growth capital to innovative companies. Its portfolio featured prominent Finnish and Scandinavian entities, including Biotie Therapies, Juvantia Pharma, and Carbion. In 2008, BioFund was acquired by CapMan, a major Nordic private equity asset manager, to serve as the foundation for its dedicated healthcare investment team. This acquisition marked the integration of BioFund's specialized expertise into a broader regional investment platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio Fund Ventures.